Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Common Equity: 2009-2024

Historic Common Equity for National Healthcare (NHC) over the last 16 years, with FY2024 value amounting to $983.2 million.

  • National Healthcare's Common Equity rose 723.87% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 723.87%. This contributed to the annual value of $983.2 million for FY2024, which is 798.29% up from last year.
  • National Healthcare's Common Equity amounted to $983.2 million in FY2024, which was up 798.29% from $910.5 million recorded in FY2023.
  • National Healthcare's Common Equity's 5-year high stood at $983.2 million during FY2024, with a 5-year trough of $798.3 million in FY2020.
  • Moreover, its 5-year median value for Common Equity was $908.5 million (2021), whereas its average is $895.6 million.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 1380.5% in 2021, then crashed by 340.64% in 2022.
  • Over the past 5 years, National Healthcare's Common Equity (Annual) stood at $798.3 million in 2020, then grew by 13.81% to $908.5 million in 2021, then dropped by 3.41% to $877.5 million in 2022, then rose by 3.76% to $910.5 million in 2023, then rose by 7.98% to $983.2 million in 2024.
  • Its Common Equity was $983.2 million in FY2024, compared to $910.5 million in FY2023 and $877.5 million in FY2022.